ResMed | RMD - Operating Profit


ResMed reported $505.67M in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Ansell USD 146.5M 87.85M Dec/2025
Artivion USD 4.79M 6.85M Dec/2025
AtriCure USD 9.66M 9.14M Jun/2026
Baxter International USD 276M 210M Jun/2026
Cochlear AUD 261.1M 135.55M Dec/2025
Cooper Companies USD -31M 243.8M Mar/2026
CSL USD 2.64B 1.97B Dec/2025
Dexcom USD 318.3M 63M Jun/2026
Edwards Lifesciences USD 519.5M 4.8M Jun/2026
Fisher Paykel Healthcare NZD 368.8M 70.6M Jun/2026
Globus Medical USD 164M 17.31M Mar/2026
Haemonetics USD 57.46M 5.12M Jun/2026
Idexx Laboratories USD 425.57M 62.98M Jun/2026
Inogen USD -7.79M 728K Sep/2024
Insulet USD 129.7M 7.7M Jun/2026
Integra LifeSciences USD 41.29M 29.82M Jun/2026
Intuitive Surgical USD 977.6M 117.9M Jun/2026
Medtronic USD 2.09B 354M Mar/2026
Philips EUR 610M 308M Jun/2026
Ramsay Health Care AUD 541.1M 3.9M Dec/2025
ResMed USD 505.67M 8.07M Mar/2026
Sigma Healthcare AUD 809K 13.76M Dec/2024
Sonic Healthcare AUD 435.76M 193.66M Dec/2024
Steris USD 285.8M 32.9M Jun/2026
Teleflex USD 37.03M 686K Mar/2026
Thermo Fisher Scientific USD 2.18B 273M Jun/2026